![A Pathway Genomics OME app user might have genetic variants responsible for metabolizing fats or for feeling sated. OME would then consider this information when providing genetically optimal diet plans or even restaurant and menu recommendations. [iStock /Warrengoldswain]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/493.jpeg "salad man dish")
Pathway Genomics and IBM unveiled the closed-alpha release of Pathway Genomics OME™ app, powered by Watson. The app merges cognitive computing and deep learning with precision medicine and genetics to enable Pathway Genomics to provide consumers with personalized wellness information, according to Michael Nova, M.D., chief innovation officer.
This alpha version of the app incorporates information from Pathway’s “FIT” test, which is a wellness-based diet, exercise, and metabolism report compiled with information from the user’s unique genetic traits, as well as their health habits, data from GPS, and wearable health monitors in addition to information from the user’s Apple HealthKit. Future versions of Pathway’s OME will enable users to opt-in to include electronic health records, insurance information, and additional datasets that will enable OME to provide precise and actionable wellness recommendations, added Dr. Nova.
For example, a user might have genetic variants responsible for metabolizing fats or for feeling sated. OME would then consider this information when providing genetically optimal diet plans or even restaurant and menu recommendations. Studies show that users who follow a genetically informed diet can lose significantly more weight that those who follow a one-size-fits-all type of plan.
To read the rest of this article click here.
